Vaishali Pharma has approved the re-appointment of its Managing Director, Whole-Time Director, and an Independent Director for five-year terms. The Board of Directors met on May 23, 2026, to ratify the appointments, which are subject to the approval of the company's shareholders. The decisions ensure continuity in leadership as the company continues its operations in the pharmaceutical industry.

The Board re-appointed Mr. Atul Arvind Vasani as Managing Director, a position he has held since the company's incorporation. His term is set for five consecutive years from May 23, 2026, to May 22, 2031. Mrs. Jagruti Vasani was also re-appointed as Whole-Time Director for a similar five-year term ending on May 22, 2031. Additionally, the Board approved the second term of Mr. Pratik Vikram Jakhelia as an Independent Director for five years from September 30, 2026, to September 29, 2031.

Director Profiles and Terms

The re-appointments follow the recommendations of the Nomination and Remuneration Committee. The detailed profiles and terms of the appointed directors are outlined below:

Mr. Atul Vasani, aged 62, is the Promoter, Chairman, and Managing Director with around three decades of experience in the pharmaceutical industry. Mrs. Jagruti Vasani, aged 60, is the Promoter and Whole-Time Director who oversees the Human Resource Department. Mr. Pratik Vikram Jakhelia is a Fellow Member of the Institute of Chartered Accountants of India with 25 years of experience in accounts and education.

Disclosures and Compliance

The company disclosed that Mrs. Jagruti Vasani is the wife of Mr. Atul Vasani. Mr. Dewansh Vasani is identified as the brother's son of Mr. Atul Vasani. The necessary information regarding these appointments was submitted in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The Board confirmed that none of the directors are debarred from holding the office of Director by virtue of any SEBI order or other authority.